Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Microfluidic Device for Cancer Detection Precisely Separates Tumor Entities

By LabMedica International staff writers
Posted on 15 Apr 2024

Tumor cell clusters are increasingly recognized as crucial in cancer pathophysiology, with growing evidence of their increased resistance to treatment and higher metastatic potential compared to single tumor cells. However, traditional cell separation techniques, which typically focus on isolating single tumor cells, are inadequate for simultaneously purifying tumor cell clusters. In response, researchers have developed a microfluidic method capable of high-throughput, continuous-flow ternary separation of single tumor cells, tumor cell clusters, and white blood cells (WBCs) from clinical samples of pleural or abdominal effusions. This technique incorporates slanted spiral channels and periodic contraction-expansion arrays to achieve separation.

The novel spiral-contraction-expansion device developed by researchers from Southeast University (Nanjing, China) utilizes slanted spiral channels combined with periodic contraction-expansion arrays for high-throughput, continuous-flow ternary separation of tumor cells and tumor cell clusters from a background of blood cells. By introducing periodic contraction-expansion arrays, the spiral-contraction-expansion device allows for the size-based ternary separation of cells under the combined action of the inertial lift force, Dean drag force, and local vortex-induced lift force. The researchers first characterized the ternary inertial focusing of differently sized particles in their spiral-contraction-expansion device and optimized the operational flow rate.

Subsequent evaluation was conducted of the device’s separation performance, recovery ratio, and purity of the tumor cells and clusters. The researchers also examined the device’s ability to carry out ternary separation of exfoliated tumor cells, tumor cell clusters, and WBCs from clinical pleural or abdominal effusions derived from cancer patients. The spiral-contraction-expansion device provides numerous benefits, including label-free, continuous-flow, high-throughput separation of tumor cells and clusters from cancer patient effusions in a single step. This method offers significant potential for enhancing the diagnosis and monitoring of treatment in cancer patients by analyzing malignant effusions with higher precision and efficiency.

Related Links:
Southeast University

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED
New
Multi-Function Pipetting Platform
apricot PP5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.